One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention

Background: Bivalirudin reduces ischemic and hemorrhagic events in patients undergoing primary percutaneous coronary intervention (PCI), but the safety and efficacy for such individuals are unclear. Our aim was to evaluate the long-term safety and efficacy of bivalirudin in patients undergoing elect...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Jiawen Li, Yulong Li, Shuhong Su, Zhifang Wang, Haiwei Liu, Weixian Yang, Shubin Qiao, Yuejin Yang, Bo Xu, Runlin Gao, Jinqing Yuan, Xueyan Zhao
Format:	Artigo
Język:	Inglês
Wydane:	IMR Press 2023-07-01
Seria:	Reviews in Cardiovascular Medicine
Hasła przedmiotowe:	bivalirudin elective percutaneous coronary intervention glycoprotein iib/iiia inhibitors unfractionated heparin
Dostęp online:	https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408218
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!